{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:38:54Z","timestamp":1792215534257,"version":"4.4.0"},"reference-count":82,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lineage plasticity and stemness have been invoked as causes of therapy resistance in cancer, because these flexible states allow cancer cells to dedifferentiate and alter their dependencies. We investigated such resistance mechanisms in relapsed\/refractory early T-cell progenitor acute lymphoblastic leukemia (ETP-ALL) carrying activating NOTCH1 mutations via full-length single-cell RNA sequencing (scRNA-seq) of malignant and microenvironmental cells. We identified 2 highly distinct stem-like states that critically differed with regard to cell cycle and oncogenic signaling. Fast-cycling stem-like leukemia cells demonstrated Notch activation and were effectively eliminated in patients by Notch inhibition, whereas slow-cycling stem-like cells were Notch independent and rather relied on PI3K signaling, likely explaining the poor efficacy of Notch inhibition in this disease. Remarkably, we found that both stem-like states could differentiate into a more mature leukemia state with prominent immunomodulatory functions, including high expression of the LGALS9 checkpoint molecule. These cells promoted an immunosuppressive leukemia ecosystem with clonal accumulation of dysfunctional CD8+ T cells that expressed HAVCR2, the cognate receptor for LGALS9. Our study identified complex interactions between signaling programs, cellular plasticity, and immune programs that characterize ETP-ALL, illustrating the multidimensionality of tumor heterogeneity. In this scenario, combination therapies targeting diverse oncogenic states and the immune ecosystem seem most promising to successfully eliminate tumor cells that escape treatment through coexisting transcriptional programs.<\/jats:p>","DOI":"10.1182\/blood.2019004547","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:44:58Z","timestamp":1606171498000},"page":"2463-2480","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":90,"title":["Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL"],"prefix":"10.1182","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-7042","authenticated-orcid":false,"given":"Praveen","family":"Anand","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6772-9950","authenticated-orcid":false,"given":"Amy","family":"Guillaumet-Adkins","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8621-7301","authenticated-orcid":false,"given":"Valeriya","family":"Dimitrova","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyoung","family":"Yun","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-2995","authenticated-orcid":false,"given":"Yotam","family":"Drier","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noori","family":"Sotudeh","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-1795","authenticated-orcid":false,"given":"Anna","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-1675","authenticated-orcid":false,"given":"Madhu M.","family":"Ouseph","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-1222","authenticated-orcid":false,"given":"Sayalee","family":"Potdar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1721-529X","authenticated-orcid":false,"given":"Randi","family":"Isenhart","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6646-564X","authenticated-orcid":false,"given":"Jake A.","family":"Kloeber","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushara","family":"Vijaykumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffaney","family":"Vincent","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-9673","authenticated-orcid":false,"given":"Julia","family":"Frede","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian H.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-4213","authenticated-orcid":false,"given":"Andrew E.","family":"Place","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Boston Children\u2019s Hospital, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis B.","family":"Silverman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Boston Children\u2019s Hospital, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-8987","authenticated-orcid":false,"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-0226","authenticated-orcid":false,"given":"Andrew A.","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7865-2306","authenticated-orcid":false,"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C.","family":"Aster","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pathology, Massachusetts General Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-2445","authenticated-orcid":false,"given":"Jens G.","family":"Lohr","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-0535","authenticated-orcid":false,"given":"Birgit","family":"Knoechel","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, MA;"},{"name":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Division of Hematology\/Oncology, Department of Medicine, Boston Children\u2019s Hospital, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2021050614051602000_B1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2021050614051602000_B2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOH.0b013e3283623c61","article-title":"Early T-cell precursor acute lymphoblastic leukaemia","volume":"20","author":"Haydu","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2021050614051602000_B3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"issue":"7380","key":"2021050614051602000_B4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"11","key":"2021050614051602000_B5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2021050614051602000_B6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood-2017-07-794214","article-title":"Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia","volume":"131","author":"Bride","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2021050614051602000_B7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2016.03.008","article-title":"The public repository of xenografts enables discovery and randomized phase II-like trials in mice [published correction appears in Cancer Cell. 2016;30(1):183]","volume":"29","author":"Townsend","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"2021050614051602000_B8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat Protoc"},{"issue":"15","key":"2021050614051602000_B9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2021050614051602000_B10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"2021050614051602000_B11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2021050614051602000_B12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"2021050614051602000_B13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nmeth.3734","article-title":"Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis","volume":"13","author":"Fan","year":"2016","journal-title":"Nat Methods"},{"issue":"4","key":"2021050614051602000_B14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2021050614051602000_B15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"7719","key":"2021050614051602000_B16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","article-title":"RNA velocity of single cells","volume":"560","author":"La Manno","year":"2018","journal-title":"Nature"},{"issue":"3","key":"2021050614051602000_B17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"6190","key":"2021050614051602000_B18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"6282","key":"2021050614051602000_B19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"18","key":"2021050614051602000_B20","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/bioinformatics\/bty316","article-title":"CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones","volume":"34","author":"M\u00fcller","year":"2018","journal-title":"Bioinformatics"},{"issue":"10","key":"2021050614051602000_B21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The Immunological Genome Project: networks of gene expression in immune cells","volume":"9","author":"Heng","year":"2008","journal-title":"Nat Immunol"},{"issue":"5","key":"2021050614051602000_B22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cels.2016.10.021","article-title":"The BLUEPRINT data analysis portal","volume":"3","author":"Fern\u00e1ndez","year":"2016","journal-title":"Cell Syst"},{"issue":"11","key":"2021050614051602000_B23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat Methods"},{"issue":"1","key":"2021050614051602000_B24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"2021050614051602000_B25","doi-asserted-by":"crossref","first-page":"E2423","DOI":"10.1002\/humu.22771","article-title":"Oncotator: cancer variant annotation tool","volume":"36","author":"Ramos","year":"2015","journal-title":"Hum Mutat"},{"issue":"1","key":"2021050614051602000_B26","doi-asserted-by":"crossref","first-page":"a000539","DOI":"10.1101\/mcs.a000539","article-title":"Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the \u03b3-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case","volume":"1","author":"Knoechel","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"6","key":"2021050614051602000_B27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nbt.3498","article-title":"The contribution of cell cycle to heterogeneity in single-cell RNA-seq data","volume":"34","author":"McDavid","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2021050614051602000_B28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nmeth.2967","article-title":"Bayesian approach to single-cell differential expression analysis","volume":"11","author":"Kharchenko","year":"2014","journal-title":"Nat Methods"},{"issue":"1","key":"2021050614051602000_B29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41467-020-14976-9","article-title":"Embracing the dropouts in single-cell RNA-seq analysis","volume":"11","author":"Qiu","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"2021050614051602000_B30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"2021050614051602000_B31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The Varied Roles of Notch in Cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"5694","key":"2021050614051602000_B32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"5","key":"2021050614051602000_B33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ng2025","article-title":"Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia","volume":"39","author":"Lahortiga","year":"2007","journal-title":"Nat Genet"},{"issue":"26","key":"2021050614051602000_B34","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1182\/blood-2010-12-317990","article-title":"ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer","volume":"117","author":"Thoms","year":"2011","journal-title":"Blood"},{"issue":"13","key":"2021050614051602000_B35","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med"},{"issue":"5","key":"2021050614051602000_B36","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2015.10.007","article-title":"The PIAS-like coactivator Zmiz1 is a direct and selective cofactor of Notch1 in T cell development and leukemia","volume":"43","author":"Pinnell","year":"2015","journal-title":"Immunity"},{"issue":"2","key":"2021050614051602000_B37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/0008-5472.CAN-12-1389","article-title":"Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias","volume":"73","author":"Rakowski","year":"2013","journal-title":"Cancer Res"},{"issue":"12","key":"2021050614051602000_B38","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"2021050614051602000_B39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41375-018-0127-8","article-title":"Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia","volume":"32","author":"De Bie","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2021050614051602000_B40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.exphem.2014.03.001","article-title":"Global analysis of induced transcription factors and cofactors identifies Tfdp2 as an essential coregulator during terminal erythropoiesis","volume":"42","author":"Chen","year":"2014","journal-title":"Exp Hematol"},{"issue":"8","key":"2021050614051602000_B41","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1074\/jbc.M115.679332","article-title":"Transcriptional regulation of JARID1B\/KDM5B histone demethylase by Ikaros, histone deacetylase 1 (HDAC1), and casein kinase 2 (CK2) in B-cell acute lymphoblastic leukemia","volume":"291","author":"Wang","year":"2016","journal-title":"J Biol Chem"},{"issue":"1","key":"2021050614051602000_B42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2012-05-428938","article-title":"SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia","volume":"121","author":"Ramezani-Rad","year":"2013","journal-title":"Blood"},{"issue":"7757","key":"2021050614051602000_B43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"1","key":"2021050614051602000_B44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.stem.2018.10.016","article-title":"IKZF2 drives leukemia stem cell self-renewal and inhibits myeloid differentiation","volume":"24","author":"Park","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2021050614051602000_B45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc3597","article-title":"Unravelling cancer stem cell potential","volume":"13","author":"Beck","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"7661","key":"2021050614051602000_B46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"issue":"1","key":"2021050614051602000_B47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.133.1.157","article-title":"Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells","volume":"133","author":"Civin","year":"1984","journal-title":"J Immunol"},{"issue":"1","key":"2021050614051602000_B48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3324\/haematol.2015.135921","article-title":"The role of CD44 in fetal and adult hematopoietic stem cell regulation","volume":"101","author":"Cao","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"2021050614051602000_B49","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.celrep.2016.08.064","article-title":"Bcl11a deficiency leads to hematopoietic stem cell defects with an aging-like phenotype","volume":"16","author":"Luc","year":"2016","journal-title":"Cell Rep"},{"issue":"43","key":"2021050614051602000_B50","doi-asserted-by":"crossref","first-page":"E10109","DOI":"10.1073\/pnas.1813015115","article-title":"Human leukemia mutations corrupt but do not abrogate GATA-2 function","volume":"115","author":"Katsumura","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"2021050614051602000_B51","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2018-12-889725","article-title":"NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML","volume":"133","author":"Sasca","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2021050614051602000_B52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3324\/haematol.10603","article-title":"The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL\/lpr mice","volume":"92","author":"Wang","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"2021050614051602000_B53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin Immunol"},{"issue":"48","key":"2021050614051602000_B54","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","article-title":"Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation","volume":"23","author":"Palacios","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"2021050614051602000_B55","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s41590-018-0238-4","article-title":"Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16","volume":"19","author":"Hosokawa","year":"2018","journal-title":"Nat Immunol"},{"issue":"50","key":"2021050614051602000_B56","doi-asserted-by":"crossref","first-page":"50791","DOI":"10.1074\/jbc.M308034200","article-title":"CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor","volume":"278","author":"Mu\u00f1oz","year":"2003","journal-title":"J Biol Chem"},{"issue":"5","key":"2021050614051602000_B57","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"4","key":"2021050614051602000_B58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ng.2913","article-title":"An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia","volume":"46","author":"Knoechel","year":"2014","journal-title":"Nat Genet"},{"issue":"suppl 3","key":"2021050614051602000_B59","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3816\/CLM.2009.s.013","article-title":"Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia","volume":"9","author":"Palomero","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"46","key":"2021050614051602000_B60","doi-asserted-by":"crossref","first-page":"E4946","DOI":"10.1073\/pnas.1407079111","article-title":"Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia","volume":"111","author":"Yashiro-Ohtani","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"2021050614051602000_B61","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1182\/blood-2008-02-136762","article-title":"Targeting the Notch1 and mTOR pathways in a mouse T-ALL model","volume":"113","author":"Cullion","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2021050614051602000_B62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"issue":"7519","key":"2021050614051602000_B63","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature13495","article-title":"Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia","volume":"513","author":"Dail","year":"2014","journal-title":"Nature"},{"issue":"10","key":"2021050614051602000_B64","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"issue":"18","key":"2021050614051602000_B65","doi-asserted-by":"crossref","first-page":"30199","DOI":"10.18632\/oncotarget.16320","article-title":"Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset","volume":"8","author":"Padi","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"2021050614051602000_B66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"issue":"3","key":"2021050614051602000_B67","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade [published correction appears in Nat Immunol. 2019;20(11):1556]","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"issue":"8","key":"2021050614051602000_B68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2021050614051602000_B69","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2018.10.047","article-title":"Analysis of single-cell RNA-seq identifies cell-cell communication associated with tumor characteristics","volume":"25","author":"Kumar","year":"2018","journal-title":"Cell Rep"},{"issue":"3","key":"2021050614051602000_B70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","article-title":"A TIM-3\/Gal-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemic progression","volume":"17","author":"Kikushige","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2021050614051602000_B71","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"issue":"47","key":"2021050614051602000_B72","doi-asserted-by":"crossref","first-page":"36969","DOI":"10.1074\/jbc.M110.163402","article-title":"X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose","volume":"285","author":"Yoshida","year":"2010","journal-title":"J Biol Chem"},{"issue":"7628","key":"2021050614051602000_B73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature20123","article-title":"Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma","volume":"539","author":"Tirosh","year":"2016","journal-title":"Nature"},{"issue":"5","key":"2021050614051602000_B74","doi-asserted-by":"crossref","first-page":"e0193849","DOI":"10.1371\/journal.pone.0193849","article-title":"Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy","volume":"13","author":"Ksionda","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"2021050614051602000_B75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2019002220","article-title":"Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia","volume":"135","author":"Li","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2021050614051602000_B76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suv\u00e0","year":"2014","journal-title":"Cell"},{"issue":"1","key":"2021050614051602000_B77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","article-title":"Single-cell RNA sequencing in cancer: lessons learned and emerging challenges","volume":"75","author":"Suv\u00e0","year":"2019","journal-title":"Mol Cell"},{"issue":"6332","key":"2021050614051602000_B78","doi-asserted-by":"crossref","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","article-title":"Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq","volume":"355","author":"Venteicher","year":"2017","journal-title":"Science"},{"issue":"6","key":"2021050614051602000_B79","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"4","key":"2021050614051602000_B80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2021050614051602000_B81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2021050614051602000_B82","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-019-0255-8","article-title":"Immune-checkpoint inhibition as first-line therapy for Hodgkin lymphoma","volume":"16","author":"Alencar","year":"2019","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/18\/2463\/1806799\/bloodbld2019004547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/18\/2463\/1806799\/bloodbld2019004547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:38:14Z","timestamp":1697200694000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/18\/2463\/474247\/Single-cell-RNA-seq-reveals-developmental"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":82,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,5,6]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019004547","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}